Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed question first answered answering member label
tabling member	label

Search

1279778

registered interest
date	25/01/2021
answering body	Department for Business, Energy and Industrial Strategy
answering dept id	201
answering dept short name	Business, Energy and Industrial Strategy
answering dept sort name	Business, Energy and Industrial Strategy
hansard heading	Coronavirus: Vaccination
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government, further to the Written Answer by Lord Callanan on 21 January (HL11869), with which companies they have entered into any contracts relating to the production of COVID-19 vaccines; and what plans they have to make the terms of those contracts available to the public.
tabling member printed	Lord Campbell-Savours
uin	HL12477
answer	answer is ministerial correction date of answer 08/02/2021 answer text <p>The UK Government has secured early access to 457 million vaccines doses through agreements with eight separate vaccine developers. This includes agreements with BioNTech/Pfizer, University of Oxford/AstraZeneca, GlaxoSmithKline/Sanofi Pasteur, Novavax, Janssen, Valneva, Moderna and CureVac.</p><p>In addition to the above, we have also funded fill and finish capability through a contract with Wockhardt in Wrexham, North Wales, as well as the expansion of the Valneva factory in Livingston, Scotland.</p><p> </p> answering member printed Lord Callanan question first answered 08/02/2021 17:03:26 answering member 4336 label Biography information for Lord Callanan
tabling member	499 label Biography information for Lord Campbell-Savours

1278940

registered interest
date	20/01/2021
answering body	Department for Business, Energy and Industrial Strategy
answering dept id	201
answering dept short name	Business, Energy and Industrial Strategy
answering dept sort name	Business, Energy and Industrial Strategy
hansard heading	Coronavirus: Vaccination
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what was the total number of (1) Oxford/AstraZeneca, and (2) Pfizer/BioNTech, COVID-19 vaccine vials allocated to the UK held in stock in each month in (a) 2019, and (b) 2020.
tabling member printed	Lord Campbell-Savours
uin	HL12335
answer	answer is ministerial correction date of answer 03/02/2021 answer text <p>We have been monitoring the requirements across the supply chain from supplier through to patient for some time. There are clear supply chain plans in place for both the supply and onward deployment of all vaccine candidates. This includes materials, manufacturing, transportation, storage and distribution.</p><p> </p><p>Vaccines and vials are a precious resource in very high demand across the world and therefore for security reasons it is not possible to provide detail about the size of our supplies and exact detail about future deliveries. It should be noted that the UK has a sufficient number of glass vials available, due to orders already placed.</p> answering member printed Lord Callanan question first answered 03/02/2021 17:46:24 answering member 4336 label Biography information for Lord Callanan
tabling member	499 label Biography information for Lord Campbell-Savours

1278944

registered interest
date	20/01/2021
answering body	Department for Business, Energy and Industrial Strategy
answering dept id	201
answering dept short name	Business, Energy and Industrial Strategy
answering dept sort name	Business, Energy and Industrial Strategy
hansard heading	Coronavirus: Vaccination
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government whether they plan to publish the details of the contract they have with AstraZeneca for the supply of 30 million COVID-19 vaccine doses and vials; if so, (a) when, and (b) how; and if not, why not.
tabling member printed	Lord Campbell-Savours
uin	HL12339
answer	answer is ministerial correction date of answer 03/02/2021 answer text <p>Contracts between the Government and companies developing and producing COVID-19 vaccines will be published in due course.</p> answering member printed Lord Callanan question first answered 03/02/2021 17:27:46 answering member 4336 label Biography information for Lord Callanan
tabling member	499 label Biography information for Lord Campbell-Savours

1278945

registered interest
date	20/01/2021
answering body	Department for Business, Energy and Industrial Strategy
answering dept id	201
answering dept short name	Business, Energy and Industrial Strategy
answering dept sort name	Business, Energy and Industrial Strategy
hansard heading	Coronavirus: Vaccination
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government whether they plan to publish the details of their contracts with (1) Pfizer/BioNTech for the supply of 30 million MRNA COVID-19 vaccines, (2) Janssen for the supply of 30 million doses  of the AD26COV25 vaccine, (3) GSK Sanofi Pasteur for 60 million doses of the proton adjuvanted vaccine, (4) Novavax for 60 million doses of the NVXCOV2373 vaccines, and (5) Valneva for 60 million doses of the VLA2001 vaccine; if so, (a) when, and (b) how; and if not, why not.
tabling member printed	Lord Campbell-Savours
uin	HL12340
answer	answer is ministerial correction date of answer 03/02/2021 answer text <p>Contracts between the Government and companies developing and producing COVID-19 vaccines will be published in due course.</p> answering member printed Lord Callanan question first answered 03/02/2021 17:29:46 answering member 4336 label Biography information for Lord Callanan
tabling member	499 label Biography information for Lord Campbell-Savours

1275482

registered interest
date	11/01/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what (1) estimate they made, and (2) audit they undertook, of the potential (a) demand, and (b) availability, of sub-60 degree freezer capacity in the UK prior to the Pfizer COVID-19 vaccine rollout in 2020.
tabling member printed	Lord Campbell-Savours
uin	HL11968
answer	answer is ministerial correction date of answer 01/02/2021 answer text <p>Public Health England (PHE) is responsible for the central storage and distribution of ultra-low temperature COVID-19 vaccines. In its preparations to receive vaccines, PHE determined the freezer capacity requirement to support the United Kingdom programme during summer 2020 and secured the freezers against that requirement. These were commissioned and in service before arrival of the vaccine. They provide sufficient storage for approximately five million doses of COVID-19 vaccines which require minus 60 degree Celsius storage or below.</p> answering member printed Lord Bethell question first answered 01/02/2021 12:43:26 answering member 4708 label Biography information for Lord Bethell
tabling member	499 label Biography information for Lord Campbell-Savours

1275483

registered interest
date	11/01/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government how many pharmacies (1) are currently available, or (2) can be made available, to distribute COVID-19 vaccines in (a) England, (b) Scotland, (c) Wales, and (d) Northern Ireland.
tabling member printed	Lord Campbell-Savours
uin	HL11969
answer	answer is ministerial correction date of answer 01/02/2021 answer text <p>From 14 January, six community pharmacies in England started to offer the COVID-19 vaccination service, with an additional 65 pharmacy-led sites joining from the week commencing 21 January. More pharmacies will be stood up over the coming weeks and months.</p><p> </p><p>The Department, NHS England and NHS Improvement and community pharmacy representative bodies will be working together to establish how community pharmacies’ role could be expanded further in the vaccination programme. <br></p><p>As health is a devolved matter, the commissioning of community pharmacies to provide COVD-19 vaccination in Scotland, Wales and Northern Ireland are decisions for the respective devolved administrations.</p> answering member printed Lord Bethell question first answered 01/02/2021 12:41:57 answering member 4708 label Biography information for Lord Bethell
tabling member	499 label Biography information for Lord Campbell-Savours

1275484

registered interest
date	11/01/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government how many freezer units capable of sub-60 degree storage of COVID-19 vaccines are available for use by the NHS in (1) England, (2) Northern Ireland, (3) Scotland, and (4) Wales; and where such units are located.
tabling member printed	Lord Campbell-Savours
uin	HL11970
answer	answer is ministerial correction date of answer 01/02/2021 answer text <p>Public Health England has 58 ultra-low temperature freezers which provide sufficient storage for approximately five million doses of COVID-19 vaccines which require minus 60-degree Celsius storage or lower.</p><p>The ultra-low temperature freezers are located in two national storage facilities within Great Britain and Northern Ireland, to manage the distribution of COVID-19 vaccines across the four nations. The location of the facilities are not disclosed to maintain the integrity of the sites.</p><p>At a regional level the National Health Service has made preparations including sourcing of ultra-low temperature storage to support local delivery.</p> answering member printed Lord Bethell question first answered 01/02/2021 12:42:56 answering member 4708 label Biography information for Lord Bethell
tabling member	499 label Biography information for Lord Campbell-Savours

1274571

registered interest
date	07/01/2021
answering body	Department for Business, Energy and Industrial Strategy
answering dept id	201
answering dept short name	Business, Energy and Industrial Strategy
answering dept sort name	Business, Energy and Industrial Strategy
hansard heading	Coronavirus: Vaccination
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what assessment they have made of the availability of glass vials for COVID-19 vaccine distribution.
tabling member printed	Lord Campbell-Savours
uin	HL11866
answer	answer is ministerial correction date of answer 21/01/2021 answer text <p>The UK has a sufficient number of glass vials available, due to orders already placed.</p> answering member printed Lord Callanan question first answered 21/01/2021 17:28:26 answering member 4336 label Biography information for Lord Callanan
tabling member	499 label Biography information for Lord Campbell-Savours

1274572

registered interest
date	07/01/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what assessment they have made of (1) the quantity of glass vials that will be needed to distribute COVID-19 vaccines, (2) the capacity to manufacture these vials, and (3) any procurement or delivery issues that may arise.
tabling member printed	Lord Campbell-Savours
uin	HL11867
answer	answer is ministerial correction date of answer 06/04/2021 answer text <p>The procurement of vials is the responsibility of the manufacturer and the United Kingdom Government has actively engaged with each manufacturer regarding manufacturing capacity, procurement and delivery to ensure enough stock is available, providing additional support where required. The UK has a sufficient number of glass vials available, due to orders already placed with manufacturers.</p> answering member printed Lord Bethell question first answered 06/04/2021 13:03:27 answering member 4708 label Biography information for Lord Bethell
tabling member	499 label Biography information for Lord Campbell-Savours

1274573

registered interest
date	07/01/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government whether the requirements of the contract they awarded to Wockhardt Ltd, to help in the production of COVID-19 vaccines, are currently being fulfilled.
tabling member printed	Lord Campbell-Savours
uin	HL11868
answer	answer is ministerial correction date of answer 14/04/2021 answer text <p>The Oxford/AstraZeneca vaccine is currently being filled and finished at the Wockhardt site.</p><p>The Government has recently extended Wockhardt’s contract from 18 to 24 months to ensure that we have uninterrupted capability into 2022. Specific details of contract fulfillment are commercially sensitive.</p> answering member printed Lord Bethell question first answered 14/04/2021 11:07:08 answering member 4708 label Biography information for Lord Bethell
tabling member	499 label Biography information for Lord Campbell-Savours